clinical trial · NCT07503444
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
UCB BIOSCIENCES, Inc.·phase3·not yet recruiting·n = 200
Rett Syndromefenfluramine hydrochloridePlacebo
brief summary
The purpose of this study is to investigate the efficacy of fenfluramine hydrochloride (HCl) versus placebo in study participants with Rett syndrome (RTT).
started
Mar 31, 2026
primary completion
Aug 1, 2028
completion
Nov 15, 2030
last updated
Mar 31, 2026
official title
A Phase 3 Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study With Open-Label Extension to Evaluate the Efficacy And Safety of Fenfluramine Hydrochloride in Study Participants With Rett Syndrome
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol